Magdy El Ekiaby

1.6k total citations
43 papers, 1.1k citations indexed

About

Magdy El Ekiaby is a scholar working on Hematology, Biochemistry and Management of Technology and Innovation. According to data from OpenAlex, Magdy El Ekiaby has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 12 papers in Biochemistry and 10 papers in Management of Technology and Innovation. Recurrent topics in Magdy El Ekiaby's work include Hemophilia Treatment and Research (15 papers), Platelet Disorders and Treatments (14 papers) and Blood transfusion and management (12 papers). Magdy El Ekiaby is often cited by papers focused on Hemophilia Treatment and Research (15 papers), Platelet Disorders and Treatments (14 papers) and Blood transfusion and management (12 papers). Magdy El Ekiaby collaborates with scholars based in Egypt, France and Canada. Magdy El Ekiaby's co-authors include Thierry Burnouf, Hadi Goubran, Mirjana Radosevic, M. Radosevich, Keng‐Liang Ou, Tim-Mo Chen, Makram A. Sayed, Nico Lelie, Daniel Candotti and Jean‐Pierre Allain and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Biochemistry and Journal of Clinical Microbiology.

In The Last Decade

Magdy El Ekiaby

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdy El Ekiaby Egypt 18 369 162 161 153 149 43 1.1k
Erwin Strasser Germany 23 456 1.2× 314 1.9× 166 1.0× 241 1.6× 138 0.9× 76 1.6k
Ted Eastlund United States 19 326 0.9× 23 0.1× 136 0.8× 243 1.6× 169 1.1× 43 1.4k
M. Lambermont Belgium 18 256 0.7× 13 0.1× 99 0.6× 139 0.9× 282 1.9× 49 1.3k
JP Matthews Australia 15 733 2.0× 32 0.2× 26 0.2× 170 1.1× 121 0.8× 26 1.4k
Piermario Bellavita Italy 13 212 0.6× 56 0.3× 7 0.0× 43 0.3× 293 2.0× 23 1.3k
Nina Worel Austria 28 1.5k 4.0× 24 0.1× 21 0.1× 69 0.5× 344 2.3× 122 2.3k
Alessandro Mazzoni Italy 21 143 0.4× 32 0.2× 13 0.1× 17 0.1× 199 1.3× 61 1.5k
Ruth M. Warwick United Kingdom 19 831 2.3× 9 0.1× 14 0.1× 49 0.3× 259 1.7× 56 1.2k
D Niederwieser Germany 16 612 1.7× 34 0.2× 5 0.0× 26 0.2× 302 2.0× 41 1.2k
Caterina Giovanna Valentini Italy 19 292 0.8× 14 0.1× 7 0.0× 30 0.2× 197 1.3× 62 1.1k

Countries citing papers authored by Magdy El Ekiaby

Since Specialization
Citations

This map shows the geographic impact of Magdy El Ekiaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdy El Ekiaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdy El Ekiaby more than expected).

Fields of papers citing papers by Magdy El Ekiaby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdy El Ekiaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdy El Ekiaby. The network helps show where Magdy El Ekiaby may publish in the future.

Co-authorship network of co-authors of Magdy El Ekiaby

This figure shows the co-authorship network connecting the top 25 collaborators of Magdy El Ekiaby. A scholar is included among the top collaborators of Magdy El Ekiaby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdy El Ekiaby. Magdy El Ekiaby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherief, Laila M., et al.. (2025). Glanzmann thrombasthenia: a multi-center study of demographics, clinical spectrum, and treatment efficacy. European Journal of Pediatrics. 184(5). 318–318.
2.
3.
O’Sullivan, Jamie M., Michael Makris, Augusto B. Federici, et al.. (2023). Von Willebrand Disease: Gaining a global perspective. Haemophilia. 29(4). 1104–1112. 8 indexed citations
4.
Iorio, Alfonso, Magdy El Ekiaby, Emna Gouider, et al.. (2023). PB0837 Analysis of the Change in Diagnosis of von Willebrand Disease by Region and Economic Status. Research and Practice in Thrombosis and Haemostasis. 7. 101562–101562. 1 indexed citations
5.
Ipe, Tina S., Quentin Eichbaum, Magdy El Ekiaby, et al.. (2023). Transfusion medicine research in Africa: Insights from investigators in the field. Vox Sanguinis. 118(4). 281–287. 1 indexed citations
6.
Ekiaby, Magdy El, et al.. (2023). Challenges associated with access to plasma‐derived medicinal products in low middle‐income and low‐income countries. Vox Sanguinis. 119(2). 166–170. 3 indexed citations
7.
Pierce, Glenn F., Saliou Diop, Amy L. Dunn, et al.. (2022). Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years. The Lancet Haematology. 9(9). e689–e697. 38 indexed citations
8.
Kaczmarek, Radosław, Magdy El Ekiaby, Daniel P. Hart, et al.. (2021). Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders. Haemophilia. 27(4). 515–518. 6 indexed citations
9.
Barro, Lassina, et al.. (2018). Blood transfusion in sub‐Saharan Africa: understanding the missing gap and responding to present and future challenges. Vox Sanguinis. 113(8). 726–736. 45 indexed citations
10.
Custer, Brian, Shimian Zou, Simone A. Glynn, et al.. (2018). Addressing gaps in international blood availability and transfusion safety in low‐ and middle‐income countries: a NHLBI workshop. Transfusion. 58(5). 1307–1317. 67 indexed citations
11.
Pierce, Glenn F., et al.. (2018). First‐year results of an expanded humanitarian aid programme for haemophilia in resource‐constrained countries. Haemophilia. 24(2). 229–235. 29 indexed citations
12.
Riddell, Anne, Ampaiwan Chuansumrit, Magdy El Ekiaby, & Sukesh C. Nair. (2016). Diagnostic laboratory for bleeding disorders ensures efficient management of haemorrhagic disorders. Haemophilia. 22(S5). 90–95. 7 indexed citations
13.
Goubran, Hadi, Mohamed Elemary, M. Radosevich, et al.. (2016). Impact of Transfusion on Cancer Growth and Outcome. SHILAP Revista de lepidopterología. 9. CGM.S32797–CGM.S32797. 48 indexed citations
14.
Ekiaby, Magdy El, Mariángela Vargas, Makram A. Sayed, et al.. (2015). Minipool Caprylic Acid Fractionation of Plasma Using Disposable Equipment: A Practical Method to Enhance Immunoglobulin Supply in Developing Countries. PLoS neglected tropical diseases. 9(2). e0003501–e0003501. 29 indexed citations
15.
Ekiaby, Magdy El, et al.. (2012). Outcome and relapse risks of thrombotic thrombocytopaenic purpura: an Egyptian experience. Postgraduate Medical Journal. 88(1042). 433–436. 2 indexed citations
16.
Burnouf, Thierry, et al.. (2012). Dengue virus inactivation by minipool TnBP/Triton X‐45 treatment of plasma and cryoprecipitate. Vox Sanguinis. 104(1). 1–6. 16 indexed citations
17.
Ekiaby, Magdy El, et al.. (2011). Pharmacokinetic study of minipooled solvent/detergent‐filtered cryoprecipitate factor VIII. Haemophilia. 17(5). e884–8. 17 indexed citations
18.
Israels, Sara J., Magdy El Ekiaby, Teresa Quiroga, & Diego Mezzano. (2010). Inherited disorders of platelet function and challenges to diagnosis of mucocutaneous bleeding. Haemophilia. 16(s5). 152–159. 24 indexed citations
19.
Burnouf, Thierry, et al.. (2008). Properties of a concentrated minipool solvent‐detergent treated cryoprecipitate processed in single‐use bag systems. Haemophilia. 14(5). 956–962. 19 indexed citations
20.
Burnouf, Thierry, et al.. (2006). A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable‐bag system. Transfusion. 46(12). 2100–2108. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erwin Strasser Breakdown of academic impact, for papers by Ted Eastlund Breakdown of academic impact, for papers by M. Lambermont Breakdown of academic impact, for papers by JP Matthews Breakdown of academic impact, for papers by Piermario Bellavita Breakdown of academic impact, for papers by Nina Worel Breakdown of academic impact, for papers by Alessandro Mazzoni Breakdown of academic impact, for papers by Ruth M. Warwick Breakdown of academic impact, for papers by D Niederwieser Breakdown of academic impact, for papers by Caterina Giovanna Valentini
Rankless by CCL
2026